Abstract-The HLA-A and -B antigens of 99 Greek patients with transfusion dependent homozygous beta thalassaemia were determined. The HLA antigen distribution in thalassaemic patients with a severe transfusion siderosis and in patients without signs of siderosis were compared to that of 400 healthy unrelated controls from the same population. There is an increase of HLA-B14 antigen in both groups of thalassaemics as compared with the controls. No significant difference exists in the distribution of all the other HLA antigens between the two sub-groups of thalassaemics or with the controls.
INTRODUCTION
Transfusion dependent beta-thalassaemia is commonly complicated by iron overload. This overload is mainly due to the iron content of the erythrocytes transfused; increase in intestinal iron absorption may contribute to the development of siderosis, especially in carriers of the hereditary haemochromatosis (HH) gene(s), which in several racial groups is strongly associated with HLA-A3 antigen may contribute as well [1] .
The management of transfusion siderosis in thalassaemia patients remains complex and not always successful. This emphasizes that all factors contributing to * To whom correspondence should be addressed. K. Konstantopoulos, First Department of Medicine University of Athens School of Medicine, Laikon Hospital, Athens-11527, Greece. Fax: 30-1-6537421, E-mail: kkonstan@atlas.uoa. gr iron accumulation should be taken into account and the role of each one should be evaluated in a treatment program. We studied the HLA types in Greek beta thalassaemia patients and compared distribution of the HLA antigens distribution to that in healthy unrelated controls.
MATERIALS AND METHODS
We studied 99 Greek patients (41 males and 58 females, aged from 9 to 40 yrs) all suffering from transfusion-dependent beta thalassaemia. They were all followed in the Thalassaemia Unit Agia Sophia Children's Hospital, Athens or in the Thalassaemia Clinic, First Department of Medicine, Athens University Medical School on a regular basis for a period of 4 to 27 years. For this analysis, we tested thalassaemic patients falling into two sub-groups: sub-group I and sub-group II (Table 1) as follows:
• sub-group I (33 patients, 8 males, 25 females, mean age 17.4 years): thalassaemic patients with a clear clinical picture of transfusion siderosis, indicated also by a constant value of serum ferritin more than two deviations; (according to our Table 1 . Frequency distribution of HLA-A and -B antigens tested in Greek thalassaemia patients with (I) and without (II) severe siderosis (33 and 66 respectively) and in 400 healthy unrelated controls from the same population (in numbers and percentages)
